A systematic literature review of herpes zoster incidence worldwide

por van Oorschot, Désirée, Vroling, Hilde, Bunge, Eveline, Diaz-Decaro, John, Curran, Desmond, Yawn, Barbara
Publicado 2021

Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany

por Curran, Desmond, Van Oorschot, Desirée, Matthews, Sean, Hain, Johannes, Salem, Ahmed Ehab, Schwarz, Magdalena
Publicado 2021

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis

por Watanabe, Daisuke, Mizukami, Akiko, Holl, Katsiaryna, Curran, Desmond, Van Oorschot, Desirée, Varghese, Lijoy, Shiragami, Makoto
Publicado 2018

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

por Shiragami, Makoto, Mizukami, Akiko, Kaise, Toshihiko, Curran, Desmond, Van Oorschot, Desiree, Bracke, Benjamin, Watanabe, Daisuke
Publicado 2019

Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme

por van Oorschot, Desirée A M, Hunjan, Manjit, Bracke, Benjamin, Lorenc, Stéphane, Curran, Desmond, Starkie-Camejo, Helen
Publicado 2019

1440. Meta-regression Analysis of Worldwide Herpes Zoster Incidence

por Yawn, Barbara P, Callegaro, Andrea, Fahrbach, Kyle, Neupane, Binod, Vroling, Hilde, Van Oorschot, Desiree, Curran, Desmond
Publicado 2021

Meta-Regression of Herpes Zoster Incidence Worldwide

por Curran, Desmond, Callegaro, Andrea, Fahrbach, Kyle, Neupane, Binod, Vroling, Hilde, van Oorschot, Désirée, Yawn, Barbara P.
Publicado 2021

A Cross-Sectional Concept Elicitation Study to Understand the Impact of Herpes Zoster on Patients’ Health-Related Quality of Life

por Van Oorschot, Desirée, McGirr, Ashleigh, Goulet, Philibert, Koochaki, Patricia, Pratiwadi, Ramya, Shah, Selam, Curran, Desmond
Publicado 2022

Cost effectiveness and budget impact of universal varicella vaccination in Russia

por Marijam, Alen, Safonova, Ekaterina, Scherbakov, Mikhail, Shpeer, Evgeniy, Van Oorschot, Desirée, Rudakova, Alla, Tatochenko, Vladimir, Briko, Nikolay
Publicado 2022

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

por Curran, Desmond, Van Oorschot, Desirée, Varghese, Lijoy, Oostvogels, Lidia, Mrkvan, Tomas, Colindres, Romulo, von Krempelhuber, Alfred, Anastassopoulou, Anastassia
Publicado 2017

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-suppo...

por Marijam, Alen, Schuerman, Lode, Izurieta, Patricia, Pereira, Priya, Van Oorschot, Désirée, Mehta, Shailesh, Ota, Martin OC, Standaert, Baudouin
Publicado 2022

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old

por Van Oorschot, Desirée, Anastassopoulou, Anastassia, Poulsen Nautrup, Barbara, Varghese, Lijoy, von Krempelhuber, Alfred, Neine, Mohamed, Lorenc, Stéphane, Curran, Desmond
Publicado 2018

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

por McGirr, Ashleigh, Van Oorschot, Desiree, Widenmaier, Robyn, Stokes, Michael, Ganz, Michael L., Jung, Hyosung, Varghese, Lijoy, Curran, Desmond
Publicado 2019

How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

por Han, Ru, Gomez, Jorge A., de Veras, Bruna, Pinto, Thatiana, Guzman-Holst, Adriana, Nieto, Javier, van Oorschot, Désirée A. M.
Publicado 2023

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico

por Chacon-Cruz, Enrique, Lopatynsky-Reyes, Erika Zoe, Huerta-Garcia, Gloria, Cervantes-Apolinar, Maria Yolanda, Guzman-Holst, Adriana, Van Oorschot, Desiree
Publicado 2022

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

por Curran, Desmond, Patterson, Brandon J., Van Oorschot, Desiree, Buck, Philip O., Carrico, Justin, Hicks, Katherine A., Lee, Bruce, Yawn, Barbara P.
Publicado 2019

Estimated Public Health Impact of the Recombinant Zoster Vaccine

por Patterson, Brandon J., Buck, Philip O., Curran, Desmond, Van Oorschot, Desirée, Carrico, Justin, Herring, William L., Zhang, Yuanhui, Stoddard, Jeffrey J.
Publicado 2021

Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico

por Gomez, Jorge, Velázquez, F. Raul, Guzman-Holst, Adriana, Cervantes Apolinar, Maria Yolanda, Van Bellinghen, Laure-Anne, Van Vlaenderen, Ilse, van Oorschot, Désirée
Publicado 2023

The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy

por Volpi, Antonio, Boccalini, Sara, Dari, Silvia, Clarke, Christopher, Curran, Desmond, Loiacono, Idalba, Pitrelli, Andrea, Puggina, Anna, Tosatto, Roberta, Van Oorschot, Desirée, Franco, Elisabetta
Publicado 2019

Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model

por Patterson, Brandon J, Herring, William L, Van Oorschot, Desiree, Curran, Desmond, Carrico, Justin, Zhang, Yuanhui, Ackerson, Bradley K, Bruxvoort, Katia, Sy, Lina S, Tseng, Hung-Fu
Publicado 2020